FDA Import Refusal AEK-7726918-9/10001/1 — Eli Lilly

Eli Lilly — FEI 3005720260

The FDA refused shipment AEK-7726918-9/10001/1 from Eli Lilly (United States) on Nov 14, 2025. The refused product falls under Drugs and Biologics — LISPRO INSULIN (ANTI-DIABETIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.